Skip to content
10-Q

Quarterly Report

OXYGEN THERAPY, INC.

0001493152-17-005225

← back to feed
Filed
May 15, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · May 5, 2017 19.71M sh
Operating Cash Flow Q1 2017 · Mar 31, 2017 −$104.39K
Stockholders Equity Q1 2017 · Mar 31, 2017 $109.43K
Stockholders Equity Q1 2017 · Dec 31, 2016 $253.15K
Current Liabilities Q1 2017 · Mar 31, 2017 $131.38K
Current Liabilities Q1 2017 · Dec 31, 2016 $82.23K
Current Assets Q1 2017 · Mar 31, 2017 $230.99K
Current Assets Q1 2017 · Dec 31, 2016 $325.38K
Total Assets Q1 2017 · Mar 31, 2017 $240.31K
Total Assets Q1 2017 · Dec 31, 2016 $335.38K
Sga Expense Q1 2017 · Mar 31, 2017 $152.9K
Net Income Q1 2017 · Mar 31, 2017 −$153.72K
Operating Income Q1 2017 · Mar 31, 2017 −$152.9K